articles by Joseph Kim
-
How to profit from short selling
Joseph Kim
July 22, 2019
As you likely know, short selling is a trading strategy that involves borrowing and then selling shares in a business, with the aim of buying them back and returning them when the share price falls. What you may not realise is that it’s possible to take advantage when other investors short sell a stock. Continue…
by Joseph Kim Posted in Editor's Pick, Investing Education.
- save this article
- POSTED IN Editor's Pick, Investing Education.
-
How valuable is Iluka Resources’ MAC royalty?
Joseph Kim
July 12, 2019
One mining company that does not get frequently mentioned despite being in the ASX 100 Index is Iluka Resources (ASX:ILU). The company owns a significant asset known as the “MAC royalty” receiving an extremely lucrative royalty rate on iron ore revenue generated from BHP’s Mining Area C mine. Continue…
by Joseph Kim Posted in Companies, Energy / Resources.
- 2 Comments
- save this article
- 2
- POSTED IN Companies, Energy / Resources.
-
Caltex under the pump
Joseph Kim
July 1, 2019
The 20 June announcement by Caltex clearly caught the market by surprise, let’s look at the evolving landscape in Australian petrol retailing, the competitive dynamics and how this has impacted Caltex’s profit and share price. Continue…
by Joseph Kim Posted in Companies, Consumer discretionary.
- save this article
- POSTED IN Companies, Consumer discretionary.
-
What are the best venture capital bets?
Joseph Kim
June 18, 2019
There have been a number of high-profile IPOs in the US this year – with the ride-sharing Apps Uber and Lyft being two of the most prominent. The combined valuation of the two listings at IPO was >US$100bn (Uber $82bn, Lyft $24bn), a higher valuation than every company on the ASX aside from the mighty BHP. Continue…
by Joseph Kim Posted in Companies.
- 3 Comments
- save this article
- 3
- POSTED IN Companies.
-
Is Costa Group’s share price decline cyclical or structural?
Joseph Kim
June 12, 2019
One of the more significant de-rating stories over the past 12 months has been that of fruit and vegetable grower Costa Group (ASX:CGC), which has had to issue two earnings downgrades over this period due to a variety of weaker pricing and agricultural-related issues. Continue…
by Joseph Kim Posted in Companies.
- 3 Comments
- save this article
- 3
- POSTED IN Companies.
-
Is Lynas an unlikely winner from a protracted trade war?
Joseph Kim
May 22, 2019
After initially bursting on to fund managers’ radars in early 2010 with a spike in prices, rare-earths producer Lynas (ASX:LYC) has been trading in relative obscurity for most of the decade as the company battled a myriad of issues that impacted its share price – including lower rare-earth prices, higher capital costs, regulatory uncertainty, balance sheet stress, slower than expected production ramp-up and significant board and management upheaval. Continue…
by Joseph Kim Posted in Companies.
- save this article
- POSTED IN Companies.
-
How a slowing listings environment impacts Domain and REA Group
Joseph Kim
May 13, 2019
The topic of the property market is a favourite obsession for many Australians given the significant percentage of household wealth the asset class represents for most Australians. There is plenty of media and other commentary discussing property market conditions on any given day – including from other contributors to the blog – so I won’t delve into where I think prices will go in the future. However, a slowing property market does have implications for listing volumes. Continue…
by Joseph Kim Posted in Companies, Editor's Pick, Property.
- 9 Comments
- save this article
- 9
- POSTED IN Companies, Editor's Pick, Property.
-
Where to for Avita Medical?
Joseph Kim
May 6, 2019
One company that recently caught our attention, that I believe is worth monitoring, is Avita Medical (ASX:AVH). AVH owns the patents and produces a medical device called RECELL, which produces a “suspension” of spray-on skin cells using a small sample of the patient’s own skin to help treat burn patients and skin defects. Continue…
by Joseph Kim Posted in Companies, Stocks We Like.
- 7 Comments
- save this article
- 7
- POSTED IN Companies, Stocks We Like.
-
Buy-backs and capital allocation – looking at Pro Medicus
Joseph Kim
April 16, 2019
In this week’s video insight Joseph discusses the recent share buy-back announcement of Pro Medicus (ASX:PME) and the impact to the company’s share metrics. Share buy-backs are often seen as a signal that the board views the current share price as undervaluing the company. Any buy-back using PME’s surplus cash may actually result in price earnings dilution given PME’s lofty 99x PE ratio.
by Joseph Kim Posted in Video Insights.
- watch video
- save this article
- POSTED IN Video Insights.
-
5 companies and insight from their management
Joseph Kim
April 10, 2019
With reporting season over a month past, I thought it worthwhile to review some comments made by senior management of companies during reporting season as the noise settles down and there is a period of time to reflect on what has occurred and how things may evolve over the next 6-12 months (and longer). Continue…
by Joseph Kim Posted in Companies, Editor's Pick.
- 4 Comments
- save this article
- 4
- POSTED IN Companies, Editor's Pick.
